FCBT
REGN icon

First Citizens Bank & Trust’s Regeneron Pharmaceuticals REGN Stock Holding History

First Citizens Bank & Trust’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-362
Closed -$258K – 534
2024
Q4 		$258K Buy
362
+85
+31% +$71.3K ﹤0.01% 413
2024
Q3 		$291K Sell
277
-12
-4% -$13.4K 0.01% 377
2024
Q2 		$304K Sell
289
-6
-2% -$5.82K 0.01% 369
2024
Q1 		$284K Buy
+295
New +$281K 0.01% 381
2023
Q1 		– Sell
-333
Closed -$240K – 338
2022
Q4 		$240K Buy
+333
New +$246K 0.01% 290
2020
Q4 		– Sell
-2,273
Closed -$1.27M – 403
2020
Q3 		$1.27M Buy
2,273
+42
+2% +$25.5K 0.09% 167
2020
Q2 		$1.39M Buy
+2,231
New +$1.27M 0.12% 155
2016
Q1 		– Sell
-4,455
Closed -$2.42M – 448
2015
Q4 		$2.42M Sell
4,455
-5
-0.1% -$2.71K 0.18% 110
2015
Q3 		$2.08M Sell
4,460
-150
-3% -$80.6K 0.15% 123
2015
Q2 		$2.35M Sell
4,610
-150
-3% -$73.2K 0.16% 122
2015
Q1 		$2.15M Sell
4,760
-150
-3% -$63.6K 0.15% 125
2014
Q4 		$2.01M Sell
4,910
-198
-4% -$77.9K 0.15% 117
2014
Q3 		$1.84M Buy
5,108
+1,948
+62% +$653K 0.15% 115
2014
Q2 		$893K Buy
3,160
+190
+6% +$56.3K 0.08% 167
2014
Q1 		$892K Sell
2,970
-3,464
-54% -$1.07M 0.08% 162
2013
Q4 		$1.77M Sell
6,434
-5,771
-47% -$1.66M 0.16% 116
2013
Q3 		$3.82M Buy
12,205
+5,089
+72% +$1.34M 0.15% 160
2013
Q2 		$1.6M Buy
+7,116
New +$1.66M 0.07% 271

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

First Citizens Bank & Trust's REGN Position: Q1 2025 in Review

First Citizens Bank & Trust sold out of Regeneron Pharmaceuticals (REGN) in Q1 2025, closing a stake of 362 shares — an estimated $258K sold.

First Citizens Bank & Trust first reported a position in REGN in Q2 2013 and held it in 18 quarters. The position peaked at $3.82M in Q3 2013. 1,292 funds tracked by Wall St. Rank hold REGN as of Q1 2025.

  • First Citizens Bank & Trust reported no remaining Regeneron Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • First Citizens Bank & Trust sold 362 Regeneron Pharmaceuticals shares in Q1 2025, an estimated $258K.
  • First Citizens Bank & Trust first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • First Citizens Bank & Trust's Regeneron Pharmaceuticals position peaked at $3.82M in Q3 2013.
  • 1,292 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2025.

Based on First Citizens Bank & Trust's 13F filing for Q1 2025, filed 14 Apr 2025.